![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 31, 27829-27838, August 2, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
From the The role of CT repeats (inverted GAGA box) in the
rat vasopressin V1b receptor (V1bR) promoter in the transcriptional
regulation of this gene was studied in H32 hypothalamic cells, which
express endogenous V1bR. Transfection of a 2.5-kb V1bR fragment
(2161 bp upstream and 377 bp downstream of the proximal transcriptional start point) into a luciferase vector (V1bRp2.5-Luc)
results in promoter activity in these cells. The 670-bp proximal
promoter fragment containing the GAGA box showed maximal promoter
activity, whereas deletion of the GAGA box abolished transcription.
Drosophila GAGA-binding protein increased V1bR promoter
activity by 11-fold when cotransfected with V1bRp2.5-Luc and
increased endogenous V1bR expression. Electrophoretic mobility shift
assay showed specific binding of pituitary nuclear extracts to
radiolabeled GAGA oligonucleotides, which increased following
restraint stress in rats, a condition associated with V1bR
up-regulation. DNA-binding activity involved a protein complex because
it was abolished by deoxycholate. Size-exclusion column chromatography
showed a complex of 127 kDa, which dissociated into ~70-kDa
components after deoxycholate/Nonidet P-40 treatment. This study
demonstrates that interactions of GAGA-binding proteins with the GAGA
box of the V1bR promoter activate V1bR gene expression and
provides a potential mechanism for physiological regulation of
V1bR transcription.
Section on Endocrine Physiology,
Developmental Endocrinology Branch, and the ¶ Section on
Cellular Neurobiology, Laboratory of Developmental Neurobiology,
NICHD, National Institutes of Health,
Bethesda, Maryland 20892
This article has been cited by other articles:
![]() |
D. L. Sackett, L. Ozbun, E. Zudaire, L. Wessner, J. M. Chirgwin, F. Cuttitta, and A. Martinez Intracellular Proadrenomedullin-Derived Peptides Decorate the Microtubules and Contribute to Cytoskeleton Function Endocrinology, June 1, 2008; 149(6): 2888 - 2898. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Han, W.-Y. Hu, O. Chernaya, N. Antic, L. Gu, M. Gupta, M. Piano, and P. de Lanerolle Increased Myosin Light Chain Kinase Expression in Hypertension: Regulation by Serum Response Factor via an Insertion Mutation in the Promoter Mol. Biol. Cell, September 1, 2006; 17(9): 4039 - 4050. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Volpi, Y. Liu, and G. Aguilera Vasopressin increases GAGA binding activity to the V1b receptor promoter through transactivation of the MAP kinase pathway. J. Mol. Endocrinol., June 1, 2006; 36(3): 581 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. VOLPI, C. RABADAN-DIEHL, and G. AGUILERA Regulation of Vasopressin V1b Receptors and Stress Adaptation Ann. N.Y. Acad. Sci., June 1, 2004; 1018(1): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Miyakawa, M. de Lourdes Junqueira, and J. E. Krieger Identification of two novel shear stress responsive elements in rat angiotensin I converting enzyme promoter Physiol Genomics, April 13, 2004; 17(2): 107 - 113. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |